A novel dimeric thymosin beta 4 with enhanced activities accelerates the rate of wound healing

Objective Thymosin beta 4 (Tβ4) is a peptide with 43 amino acids that is critical for repair and remodeling tissues on the skin, eye, heart, and neural system following injury. To fully realize its utility as a treatment for disease caused by injury, the authors constructed a cost-effective novel Tβ4 dimer and demonstrated that it was better able to accelerate tissue repair than native Tβ4. Methods A prokaryotic vector harboring two complete Tβ4 genes with a short linker was constructed and expressed in Escherichia coli. A pilot-scale fermentation (10 L) was performed to produce engineered bacteria and the Tβ4 dimer was purified by one-step hydrophobic interaction chromatography. The activities of the Tβ4 dimer to promote endothelial cell proliferation, migration, and sprouting were assessed by tetramethylbenzidine (methylthiazol tetrazolium), trans-well, scratch, and tube formation assays. The ability to accelerate dermal healing was assessed on rats. Results After fermentation, the Tβ4 dimer accounted for about 30% of all the bacteria proteins. The purity of the Tβ4 dimer reached 98% after hydrophobic interaction chromatography purification. An average of 562.4 mg/L Tβ4 dimer was acquired using a 10 L fermenter. In each assay, the dimeric Tβ4 exhibited enhanced activities compared with native Tβ4. Notably, the ability of the dimeric Tβ4 to promote cell migration was almost two times higher than that of Tβ4. The rate of dermal healing in the dimeric Tβ4-treated rats was approximately 1 day faster than with native Tβ4-treated rats. Conclusion The dimeric Tβ4 exhibited enhanced activity on wound healing than native Tβ4, and the purification process was simple and cost-effective. This data could be of significant benefit for the high pain and morbidity associated with chronic wounds disease. A better strategy to develop Tβ4 as a treatment for other diseases caused by injuries such as heart attack, neurotrophic keratitis, and multiple sclerosis was also described.

[1]  Hossein Hosseinkhani,et al.  Self-assembled proteins and peptides for regenerative medicine. , 2013, Chemical reviews.

[2]  H. Kleinman,et al.  The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients , 2012, Annals of the New York Academy of Sciences.

[3]  Zhaohui J. Cai,et al.  Pretreatment data is highly predictive of liver chemistry signals in clinical trials , 2012, Drug design, development and therapy.

[4]  J. Bush,et al.  Discovery and development of avotermin (recombinant human transforming growth factor beta 3): A new class of prophylactic therapeutic for the improvement of scarring , 2011, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[5]  P. Qiu,et al.  Thymosin β4 inhibits TNF‐α‐induced NF‐κB activation, IL‐8 expression, and the sensitizing effects by its partners PINCH‐1 and ILK , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  R. Ling,et al.  Expression, Purification and Characterization of A Novel Soluble Human Thymosin Alpha1 Concatemer Exhibited A Stronger Stimulation on Mice Lymphocytes Proliferation and Higher Anti-tumor Activity , 2011, International journal of biological sciences.

[7]  B. Zetter,et al.  Regenerative protein thymosin β‐4 is a novel regulator of purinergic signaling , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  M. Landthaler,et al.  Wound healing in the 21st century. , 2010, Journal of the American Academy of Dermatology.

[9]  R. Hancock,et al.  Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli , 2010, Peptides.

[10]  M. Chopp,et al.  Thymosin β4 improves functional neurological outcome in a rat model of embolic stroke , 2010, Neuroscience.

[11]  S. Bossio,et al.  Quantification of thymosin beta(4) in human cerebrospinal fluid using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2010, Analytical biochemistry.

[12]  P. Qiu,et al.  Biological activities of thymosin ß4 defined by active sites in short peptide sequences , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  P. Qiu,et al.  Thymosin β4 and corneal wound healing: visions of the future , 2010, Annals of the New York Academy of Sciences.

[14]  H. Ehrlich,et al.  Thymosin β4 enhances repair by organizing connective tissue and preventing the appearance of myofibroblasts , 2010, Annals of the New York Academy of Sciences.

[15]  R. Camerini,et al.  The effect of thymosin treatment of venous ulcers , 2010, Annals of the New York Academy of Sciences.

[16]  N. Turjman,et al.  Thymosin β4: structure, function, and biological properties supporting current and future clinical applications , 2010 .

[17]  D. Ruff,et al.  A randomized, placebo‐controlled, single and multiple dose study of intravenous thymosin β4 in healthy volunteers , 2010, Annals of the New York Academy of Sciences.

[18]  M. Chopp,et al.  Neurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis , 2009, Neuroscience.

[19]  P. Fox,et al.  Spatial coordination of actin polymerization and ILK-Akt2 activity during endothelial cell migration. , 2009, Developmental cell.

[20]  O. Lee,et al.  Thymosin beta-4 upregulates anti-oxidative enzymes and protects human cornea epithelial cells against oxidative damage , 2008, British Journal of Ophthalmology.

[21]  C. Cierniewski,et al.  Ku80 as a Novel Receptor for Thymosin β4 That Mediates Its Intracellular Activity Different from G-actin Sequestering* , 2008, Journal of Biological Chemistry.

[22]  P. Riley,et al.  Thymosin beta4 and Ac-SDKP: tools to mend a broken heart. , 2008, Journal of molecular medicine.

[23]  Xiankui Li,et al.  Recombinant thymosin beta 4 can promote full-thickness cutaneous wound healing. , 2007, Protein expression and purification.

[24]  A. Goldstein,et al.  Identification and Quantification of Thymosin β4 in Human Saliva and Tears , 2007, Annals of the New York Academy of Sciences.

[25]  Catherine A. Risebro,et al.  Thymosin β4 induces adult epicardial progenitor mobilization and neovascularization , 2007, Nature.

[26]  Tarynn M Witten,et al.  Impaired wound healing. , 2007, Clinics in dermatology.

[27]  Ali Khademhosseini,et al.  Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. , 2006, Biomaterials.

[28]  W. Fisher,et al.  Roles of Thymosins in Cancers and Other Organ Systems , 2005, World Journal of Surgery.

[29]  D. Srivastava,et al.  Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair , 2004, Nature.

[30]  M. Kurpakus-Wheater,et al.  Thymosin-beta4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro. , 2004, Investigative ophthalmology & visual science.

[31]  F. Lu,et al.  Cloning expression in E.coli and biological activity of human thymosin beta(4). , 2002, Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica.

[32]  L. Leondiadis,et al.  Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model. , 2001, Biochimica et biophysica acta.

[33]  D. Scherman,et al.  Dimeric erythropoietin fusion protein with enhanced erythropoietic activity in vitro and in vivo. , 2001, Blood.

[34]  R. Stevenson,et al.  Thymosin β 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids , 1999, Nature Medicine.

[35]  I. Wilson,et al.  Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. , 1999, Science.

[36]  I. Wilson,et al.  Erythropoietin receptor activation by a ligand-induced conformation change. , 1999, Science.

[37]  H. Kleinman,et al.  Thymosin beta4 accelerates wound healing. , 1999, The Journal of investigative dermatology.

[38]  W. Risau,et al.  Molecular mechanisms of vasculogenesis and embryonic angiogenesis , 1997, Journal of cellular physiology.

[39]  A. Goldstein,et al.  Thymosin β4 stimulates directional migration of human umbilical vein endothelial cells , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  H. Kleinman,et al.  Matrigel induces thymosin beta 4 gene in differentiating endothelial cells. , 1995, Journal of cell science.

[41]  A. Goldstein,et al.  Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin). , 1966, Proceedings of the National Academy of Sciences of the United States of America.